HAVCR2 and hepatocellular carcinoma: Furthermore, TIGIT and TIM-3 IC molecules are significantly up-regulated on NK cells in HBV-HCC patients, accompanied by substantial impairments in cytotoxic activity and cytokine production capacity [154].